文献速递肺栓塞与肺血管病间质性肺疾病

S52F FOXF1突变通过抑制STAT3信号导致肺泡毛细血管发育不良

The S52F FOXF1 Mutation Inhibits STAT3 Signaling and Causes Alveolar Capillary Dysplasia.
PubMed 文献 · Am J Respir Crit Care Med · 2019-01-01

本研究通过CRISPR/Cas9构建携带S52F Foxf1突变的ACDMPV小鼠模型,发现该突变破坏STAT3-FOXF1蛋白互作并抑制Stat3转录,导致内皮增殖和肺血管发育受损;纳米颗粒递送STAT3 cDNA可恢复新生小鼠肺血管生成,为ACDMPV治疗提供新策略。

要点

  • S52F FOXF1突变通过抑制STAT3信号导致肺泡毛细血管发育不良。
  • 纳米颗粒递送STAT3可恢复Foxf1WT/S52F小鼠内皮增殖与肺血管生成。
  • FOXF1通过STAT3调控新生儿肺血管生成。

核心结论

  • FOXF1通过STAT3促进新生儿肺血管生成,S52F FOXF1突变通过抑制STAT3信号导致ACDMPV。
  • 纳米颗粒递送STAT3 cDNA是治疗STAT3信号降低相关ACDMPV的有前景策略。

研究设计与样本

  • 研究用CRISPR/Cas9技术将S52F FOXF1突变引入小鼠Foxf1基因座,构建临床相关ACDMPV小鼠模型。
  • 在28例ACDMPV受试者中鉴定到FOXF1突变。
  • 采用免疫组化、全肺成像和生化方法检查Foxf1WT/S52F小鼠肺血管并探索FOXF1调控机制。

主要发现

  • Foxf1WT/S52F敲入小鼠重现ACDMPV婴儿的组织病理学表现。
  • S52F FOXF1突变破坏STAT3-FOXF1蛋白互作并抑制Stat3转录。
  • Foxf1WT/S52F小鼠和人ACDMPV肺中STAT3信号及内皮增殖降低。
  • S52F FOXF1突变蛋白不结合染色质且转录失活。
  • 纳米颗粒将STAT3 cDNA递送至新生小鼠循环可恢复内皮增殖并刺激肺血管生成。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Rationale: Alveolar capillary dysplasia with misalignment of pulmonary veins (ACDMPV) is a lethal congenital disorder causing respiratory failure and pulmonary hypertension shortly after birth. There are no effective treatments for ACDMPV other than lung transplant, and new therapeutic approaches are urgently needed. Although ACDMPV is linked to mutations in the FOXF1 gene, molecular mechanisms through which FOXF1 mutations cause ACDMPV are unknown.Objectives: To identify molecular mechanisms by which S52F FOXF1 mutations cause ACDMPV.Methods: We generated a clinically relevant mouse model of ACDMPV by introducing the S52F FOXF1 mutation into the mouse Foxf1 gene locus using CRISPR/Cas9 technology. Immunohistochemistry, whole-lung imaging, and biochemical methods were used to examine vasculature in Foxf1WT/S52F lungs and identify molecular mechanisms regulated by FOXF1.Measurements and Main Results: FOXF1 mutations were identified in 28 subjects with ACDMPV. Foxf1WT/S52F knock-in mice recapitulated histopathologic findings in ACDMPV infants. The S52F FOXF1 mutation disrupted STAT3-FOXF1 protein-protein interactions and inhibited transcription of Stat3, a critical transcriptional regulator of angiogenesis. STAT3 signaling and endothelial proliferation were reduced in Foxf1WT/S52F mice and human ACDMPV lungs. S52F FOXF1 mutant protein did not bind chromatin and was transcriptionally inactive. Furthermore, we have developed a novel formulation of highly efficient nanoparticles and demonstrated that nanoparticle delivery of STAT3 cDNA into the neonatal circulation restored endothelial proliferation and stimulated lung angiogenesis in Foxf1WT/S52F mice.Conclusions: FOXF1 acts through STAT3 to stimulate neonatal lung angiogenesis. Nanoparticle delivery of STAT3 is a promising strategy to treat ACDMPV associated with decreased STAT3 signaling.

来源:Am J Respir Crit Care Med,查看原文。版权归原作者所有。

引用

  1. Pradhan A, Dunn A, Ustiyan V, et al. The S52F FOXF1 Mutation Inhibits STAT3 Signaling and Causes Alveolar Capillary Dysplasia. Am J Respir Crit Care Med. 2019. PMID: 31199666. doi:10.1164/rccm.201810-1897OC

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。